Details for Patent: 9,265,720
✉ Email this page to a colleague
Which drugs does patent 9,265,720 protect, and when does it expire?
Patent 9,265,720 protects EDLUAR and is included in one NDA.
This patent has twenty patent family members in twelve countries.
Summary for Patent: 9,265,720
Title: | Pharmaceutical formulations useful in the treatment of insomnia |
Abstract: | There is provided a formulation suitable for transmucosal administration comprising a short acting hypnotic drug, which formulation provides a measurable plasma concentration of drug within 10 minutes of administration. The formulation is capable of providing sleep on demand, and preferably comprises particles of drug, for example zolpidem or a pharmaceutically-acceptable salt thereof and a mucoadhesion promoting agent, such as sodium carboxymethylcellulose, which particles of drug and mucoadhesive are presented upon the surface of larger carrier particles. |
Inventor(s): | Pettersson; Anders (Kode, SE), Nystrom; Christer (Stockholm, SE), Bredenberg; Susanne (Uppsala, SE) |
Assignee: | Orexo AB (Uppsala, SE) |
Application Number: | 11/666,361 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; Formulation; Device; |
Drugs Protected by US Patent 9,265,720
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Speciality Lp | EDLUAR | zolpidem tartrate | TABLET;SUBLINGUAL | 021997-001 | Mar 13, 2009 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING INSOMNIA CHARACTERIZED BY DIFFICULTY WITH SLEEP ONSET | ⤷ Try a Trial | |||
Mylan Speciality Lp | EDLUAR | zolpidem tartrate | TABLET;SUBLINGUAL | 021997-002 | Mar 13, 2009 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING INSOMNIA CHARACTERIZED BY DIFFICULTY WITH SLEEP ONSET | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,265,720
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 0423800.2 | Oct 27, 2004 |
PCT Information | |||
PCT Filed | October 26, 2005 | PCT Application Number: | PCT/GB2005/004147 |
PCT Publication Date: | May 04, 2006 | PCT Publication Number: | WO2006/046041 |
International Family Members for US Patent 9,265,720
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Cyprus | 1118414 | ⤷ Try a Trial | |||
Cyprus | 1119580 | ⤷ Try a Trial | |||
Denmark | 1807156 | ⤷ Try a Trial | |||
Denmark | 2340872 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |